MEDICAL MEDIA TELEVISION, INC.

                     2006 INSIDER TRADING COMPLIANCE PROGRAM

         In order to take an active role in the prevention of insider trading
violations by its officers, directors, employees and other related individuals,
the Company has adopted the policies and procedures described in this
Memorandum.

I.       Adoption of Insider Trading Policy.

         The Company has adopted the Insider Trading Policy attached as Exhibit
A (the "Policy"), which prohibits trading based on material, non-public
information regarding the Company ("Inside Information"). The Policy covers
officers, directors and all other employees of, or consultants to, the Company
or its subsidiaries, as well as family members of such persons, and others, in
each case where such persons have or may have access to Inside Information. The
Policy (and/or a summary thereof) is to be delivered to all new directors,
officers, employees and consultants on the commencement of their relationships
with the Company, and is to be circulated to all employees at least annually.

II.      Designation of Certain Persons.

         A. The Company has determined that those persons listed on Exhibit B
are the directors and officers who are subject to certain reporting and penalty
provisions of Section 16 of the Securities Exchange Act of 1934, as amended (the
"Exchange Act") and certain rules and regulations promulgated thereunder
("Section 16 Individuals"). Exhibit B may be amended by the Company from time to
time.

         B. The Company has determined that those persons listed on Exhibit C,
together with the Section 16 Individuals listed on Exhibit B, are subject to the
preclearance requirement described in Section IV.A . below, in that the Company
believes such persons have, or are likely to have, access to Inside Information
on a more frequent basis than other employees. Exhibit C may be amended from
time to time. Under special circumstances, certain persons not listed on Exhibit
C may come to have access to Inside Information for a period of time. During
such period, such persons should also be subject to the preclearance procedure
described in Section IV.A. below.

III.     Appointment of Compliance Person.

         The Company has appointed Teresa J. Bray, Vice President
Administration/Compliance of the Company (or her successor in office), as the
Company's Insider Trading Compliance Officer.

<PAGE>
                                                                               2


IV.      Duties of Insider Trading Compliance Officer.

         The duties of the Insider Trading Compliance Officer shall include, but
not be limited to, the following:

         A. Preclearance of all transactions involving the Company's securities
by those individuals listed on Exhibits B and C, in order to determine
compliance with the Policy, insider trading laws, applicable rules of Section 16
of the Exchange Act and Rule 144 promulgated under the Securities Act of 1933,
as amended (the "Securities Act").

         B. Review of Rule 10b5-1 trading programs.

         C. Assistance in the preparation of Section 16 reports (Forms 3, 4 and
5) for all Section 16 Individuals, if required.

         D. Mailing of monthly reminders to all Section 16 Individuals regarding
their obligations to report, if required.

         E. Performance of cross-checks of available materials, which may
include Forms 3, 4 and 5, Form 144, officers and directors questionnaires, and
reports received from the Company's stock administrator and transfer agent, to
determine trading activity by officers, directors and others who have, or may
have, access to Inside Information.

         F. Circulation of the Policy (and/or a summary thereof) to all
employees, including Section 16 Individuals, on an annual basis, and provision
of the Policy and other appropriate materials to new officers, directors and
others who have, or may have, access to Inside Information.

<PAGE>

                                                                               3
                                    Exhibit A

                         MEDICAL MEDIA TELEVISION, INC.

                             INSIDER TRADING POLICY

                         and Guidelines with Respect to
                   Certain Transactions in Company Securities

         This Policy provides guidelines to employees, officers and directors of
Medical Media Television, Inc. (the "Company") with respect to transactions in
the Company's securities.

                             Applicability of Policy

         This Policy applies to all transactions in the Company's securities,
including common stock, options for common stock and any other securities the
Company may issue from time to time, such as preferred stock, warrants and
convertible debentures, as well as to derivative securities relating to the
Company's stock, whether or not issued by the Company, such as exchange-traded
options. It applies to all officers of the Company, all members of the Company's
Board of Directors, and all employees of, and consultants and contractors to,
the Company and its subsidiaries who receive or have access to Material
Nonpublic Information (as defined below) regarding the Company. This group of
people, members of their immediate families, and members of their households are
sometimes referred to in this Policy as "Insiders". This Policy also applies to
any person who receives Material Nonpublic Information from any Insider.

         Any person who possesses Material Nonpublic Information regarding the
Company is an Insider for so long as the information is not publicly known. Any
employee can be an Insider from time to time, and would at those times be
subject to this Policy.

                               Statement of Policy

                                 General Policy

         It is the policy of the Company to oppose the unauthorized disclosure
of any nonpublic information acquired in the work-place and the misuse of
Material Nonpublic Information in securities trading.

                                Specific Policies

         1. Trading on Material Nonpublic Information. No director, officer or
employee of, or consultant or contractor to, the Company, and no member of the
immediate family or household of any such person, shall engage in any
transaction involving a purchase or sale of the Company's securities, including
any offer to purchase or offer to sell, during any period commencing with the
date that he or she possesses Material Nonpublic Information concerning the
Company, and ending at the close of business on the second Trading Day following
the date of public disclosure of that information, or at such time as such
nonpublic information is no longer material. As used herein, the term "Trading
Day" shall mean a day on which national stock exchanges and the National
Association of Securities Dealers, Inc. Automated Quotation System (NASDAQ) are
open for trading.
<PAGE>
                                                                               4

         2. Disclosure of Information to Others. The Company is required under
Regulation FD of the federal securities laws to avoid the selective disclosure
of Material Nonpublic Information. The Company has established procedures for
releasing material information in a manner designed to achieve broad public
dissemination of the information immediately upon its release. You may not,
therefore, disclose information to anyone outside the Company, including family
members and friends, other than in accordance with those procedures. You also
may not discuss the Company or its business in an internet "chat room" or
similar internet-based forum.

         3. Confidentially of Nonpublic Information. Nonpublic information
relating to the Company is the property of the Company and the unauthorized
disclosure of such information is forbidden.

        Potential Criminal and Civil Liability and/or Disciplinary Action

         1. Liability for Insider Trading. Insiders may be subject to penalties
of up to $1,000,000 and up to ten years in jail for engaging in transactions in
the Company's securities at a time when they have knowledge of nonpublic
information regarding the Company.

         2. Liability for Tipping. Insiders may also be liable for improper
transactions by any person (commonly referred to as a "tippee") to whom they
have disclosed nonpublic information regarding the Company or to whom they have
made recommendations or expressed opinions on the basis of such information as
to trading in the Company's securities. The Securities and Exchange Commission
(the "SEC") has imposed large penalties even when the disclosing person did not
profit from the trading. The SEC, the stock exchanges and the National
Association of Securities Dealers, Inc. use sophisticated electronic
surveillance techniques to uncover insider trading.

         3. Possible Disciplinary Actions. Employees of the Company who violate
this Policy shall also be subject to disciplinary action by the Company, which
may include ineligibility for future participation in the Company's equity
incentive plans or termination of employment.

                              Trading Restrictions

         1. Prohibition on Trading During Quarterly Blackout Periods. To ensure
compliance with this Policy and applicable federal and state securities laws,
the Company has adopted a policy that prohibits persons listed on Exhibit B or C
from buying or selling the Company's securities during a regular quarterly
"blackout" period (unless they have established a pre-arranged trading plan that
complies with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934
(the "Exchange Act")). Each blackout period begins on the 20th day of the last
month of the fiscal quarter and continues until the end of the second full
trading day after the public release of quarterly results.


<PAGE>
                                                                               5

         It should be noted that trading on dates that are outside of the
quarterly blackout periods will not relieve any one from liability if in
possession of Material Nonpublic Information concerning the Company. Although
the Company may from time to time recommend the suspension of trading by
directors, officers, employees and others because of developments known to the
Company and not yet disclosed to the public, each person is individually
responsible at all times for compliance with the prohibitions against insider
trading. Trading in the Company's securities should not be considered a "safe
harbor", and all directors, officers and other persons should use good judgment
at all times.

         2. Preclearance of Trades. No person listed on Exhibit B or C is to
purchase, sell, or otherwise engage in transactions in securities of the Company
without obtaining prior clearance of the transaction by the Insider Trading
Compliance Officer. The proposed transaction will be reviewed for compliance
with applicable regulatory requirements.

         The Company may also find it necessary, from time to time, to require
compliance with the preclearance process from certain employees, consultants and
contractors other than and in addition to those persons listed on Exhibit B and
C.

         3. Rule 10b5-1 Trading Programs. The SEC has adopted a rule that
permits insiders to trade in certain circumstances where it is clear that inside
information was not a factor in the decision to trade. Rule 10b5-1 provides that
an individual who buys or sells securities while aware of Material Nonpublic
Information does not violate Rule 10b-5 if the buying or selling is in
conformity with a binding contract, instruction or written plan that was put
into place at a time when the individual was not aware of Material Nonpublic
Information. Establishing such a pre-arranged trading plan provides an
opportunity for an Insider to limit his or her potential insider trading
liability. When trading arrangements are prearranged, it becomes clearer to the
investing public (and potential plaintiffs) that the Insider's purchases and
sales are not being prompted by his or her knowledge of current developments
within the Company, or such person's feelings about the Company's prospects.

         The Company permits its directors and officers to set up Rule 10b5-1
trading programs. However, great care must be exercised in relying on new Rule
10b5-1, for the following reasons:

         In order to meet the requirements of Rule 10b5-1, binding contracts,
instructions and written plans must: (i) lock in the amount, price and dates of
future trades; (ii) provide a formula or algorithm for determining future
trades; or (iii) delegate discretion for determining amount, price and dates to
a third party precisely as provided under the rule.

         The ability to modify provisions once locked in is limited, and
modification or termination of arrangements is risky.
<PAGE>
                                                                               6

         Although Rule 10b5-1 may help directors and officers avoid liability
under Rule 10b-5, it does not eliminate other relevant securities law
requirements and prohibitions. Therefore, buying and selling in reliance on Rule
10b5-1 must also be designed to comply with the reporting and short-swing profit
rules under Section 16 of the Exchange Act, the limitations on insider selling
imposed by Rule 144 under the Securities Act, the prohibition on trading during
administrative blackouts under 401(k) or other retirement plans, and, in some
cases, certain other securities law requirements.

         The liability avoidance provisions of Rule 10b5-1 are affirmative
defenses. If the government can prove that an individual was aware of material,
nonpublic information at the time of a purchase or sale, the burden of proving
that trading was pursuant to an adequate contract, instruction or written plan
will be on the individual. Compliance must be well documented and capable of
proof in court.

         4. Procedures for Establishing Rule 10b5-1 Trading Programs. If an
officer or director wishes to establish an arrangement designed to comply with
Rule 10b5-1, he or she must follow the procedures listed below:

         o     Arrangements must be in the form of a written contract.

         o     The contract must be reviewed and approved in advance by the
               Company's Insider Trading Compliance Officer.

         o     The contract must be entered into when the officer or director
               is not in possession of any Material Nonpublic Information and
               not subject to any blackout.

         o     The contract must either:


               o     Specify the amount of securities to be purchased or sold
                     (i.e., a set number of shares or a set dollar amount)
                     and the price and date on which the securities are to be
                     purchased or sold;

               o     Include a written formula or algorithm, for determining
                     the amount of securities to be purchased or sold and the
                     price and date of their purchase or sale; or

               o     Effectively delegate to a third party who does not have
                     access to any Inside Information all power to determine
                     how, when or whether to effect purchases or sales.

         o     The officer or director will not be permitted to cancel or
               make any changes to the contract when in possession of any
               Material Nonpublic Information or during any blackout period.

         o     Cancellations or amendments must be approved in advance by the
               Company's Insider Trading Compliance Officer and must be in
                  writing.


<PAGE>
                                                                               7

         Please be aware that the Company will likely be required to publicly
disclose any trading plan adopted by an officer or director. Additionally, the
Company will need to establish a procedure with whomever is handling the 10b5-1
transactions to ensure:

         o     Prompt filing of a Form 4 after each transaction takes place; and

         o     Compliance with SEC Rule 144 at the time of any sale.

         Most sophisticated brokers, investment bankers and advisors have
developed standard documentation for Rule 10b5-1 trading plans. If this type of
plan is adopted, we strongly recommend the officer or director work with a
brokerage firm that is experienced in these matters. In order to ensure
compliance with Rule 10b5-1, please remember that any trading plan or amendment
must be submitted to the Company's Insider Trading Compliance Officer for review
and approval in advance of entering the plan or amendment.

         5. Trading Restrictions during "Retirement Plan" Administrative
Blackout Periods. Persons listed on Exhibits B or C are prohibited from trading
in any Company securities during administrative blackout periods under 401(k)
and similar retirement plans (unless such persons have established a
pre-arranged trading plan that complies with Rule 10b5-1 promulgated under the
Exchange Act). Although the Company has historically declared very few such
administrative blackout periods, any profits realized from a prohibited
transaction are recoverable by the Company, including through a shareholder
derivative-type action, without regard to intent. In addition, unlike Section 16
of the Exchange Act, no matching transaction within the blackout period is
required in order to impose the disgorgement penalty. The Company's Insider
Trading Compliance Officer will advise you whenever an administrative blackout
is imposed with respect to the Company's 401(k) or other retirement plans.

         6. Individual Responsibility. Every officer, director and employee has
the individual responsibility to comply with this Policy against insider
trading. An Insider may, from time to time, have to forego a proposed
transaction in the Company's securities even if he or she planned to make the
transaction before learning of the Material Nonpublic Information and even
though the Insider believes he or she may suffer an economic loss or forego
anticipated profit by waiting.

                  Applicability of Policy to Inside Information
                            Regarding Other Companies

         This Policy and the guidelines described herein also apply to Material
Nonpublic Information relating to other companies, including the Company's
customers, vendors or suppliers ("business partners"), when that Material
Nonpublic Information is obtained in the course of employment with, or other
services performed on behalf of, the Company. Civil and criminal penalties, and
termination of employment, may result from trading on Inside Information
regarding the Company's business partners. All employees should treat Material
Nonpublic Information about the Company's business partners with the same care
required with respect to information related directly to the Company.

<PAGE>
                                                                               8

                  Definition of Material Nonpublic Information

         It is not possible to define all categories of material information.
However, information should be regarded as material if there is a reasonable
likelihood that it would be considered important to an investor in making an
investment decision regarding the purchase or sale of the Company's securities.

         While it may be difficult under this standard to determine whether
particular information is material, there are various categories of information
that are particularly sensitive and, as a general rule, should always be
considered material. Examples of such information may include:

                   o    Financial results
                   o    Projections of future earnings or losses
                   o    News of a pending or proposed merger
                   o    News of the disposition of a subsidiary
                   o    Impending bankruptcy or financial liquidity problems
                   o    Gain or loss of a substantial customer or supplier
                   o    Changes in dividend policy
                   o    New product announcements of a significant nature
                   o    Significant news about potential products
                   o    Significant product defects or modifications
                   o    Significant pricing changes
                   o    Stock splits
                   o    New equity or debt offerings
                   o    Acquisitions
                   o    Significant litigation exposure due to actual or
                        threatened litigation
                   o   Major changes in senior management.

Either positive or negative information may be material.

         Nonpublic information is information that has not been previously
disclosed to the general public and is otherwise not available to the general
public.

                               Certain Exceptions

         For purposes of this Policy, the Company considers that the exercise of
stock options for cash under the Company's stock option plans or the purchase of
shares under the Company's employee stock purchase plan (but not the sale of any
such shares) is exempt from this Policy, since the other party to the
transaction is the Company itself and the price does not vary with the market
but is fixed by the terms of the option agreement or the plan.

<PAGE>
                                                                               9

                 Additional Information - Directors and Officers

         Directors and officers of the Company must also comply with the
reporting obligations and limitations on short-swing transactions set forth in
Section 16 of the Securities Exchange Act of 1934, as amended. The practical
effect of these provisions is that officers and directors who purchase and sell
the Company's securities within a six-month period must disgorge all profits to
the Company whether or not they had knowledge of any Material Nonpublic
Information. Under these provisions, and so long as certain other criteria are
met, neither the receipt of an option under the Company's option plans, nor the
exercise of that option nor the receipt of stock under the Company's employee
stock purchase plan is deemed a purchase under Section 16; however, the sale of
any such shares is a sale under Section 16 and the purchase and sale must be
reported on Form 4. Moreover, no officer or director may ever make a short sale
of the Company's stock. The Company has provided, or will provide, separate
memoranda and other appropriate materials to its officers and directors
regarding compliance with Section 16 and its related rules.

                                 Certifications

         All Company officers, directors, employees and coonsultants will be
required to certify in writing their understanding of and intent to comply with
the Insider Trading Policy. In addition, Company officers, directors, employees
and consultants may be required to certify their compliance with the Insider
Trading Policy on an annual basis.


                                    Inquiries

         Please direct your questions as to any of the matters discussed in this
Policy to the Company's Insider Trading Compliance Officer.

                                  Certification

         The undersigned, employee, officer, director or consultant of Medical
Media Television, Inc. and its subsidiaries and/or related corporations, hereby
certifies that he/she has carefully read and understands and agrees to comply
with the Company's Insider Trading Policy and Guidelines with Respect to Certain
Transactions in Company Securities, a copy of which was distributed to the
undersigned along with this Certification.

Date: ___________________, 2006.
                                        ------------------------------
                                        (Signature)

                                        ------------------------------
                                        (Print Name)

                                        ------------------------------
                                        (Department)

<PAGE>

                                                                              10

                                    Exhibit B

                  OFFICERS AND DIRECTORS SUBJECT TO SECTION 16

1.   Directors:

           ALL

2.   Officers:

           ALL



<PAGE>

                                                                              11


                                    Exhibit C

               OTHER EMPLOYEES SUBJECT TO PRE-CLEARANCE PROCEDURES

         Name                                            Title